JPS6470418A - Auricular sodium diuretic factor for treatment of cardiac disease, partial arrangement and use of analog - Google Patents

Auricular sodium diuretic factor for treatment of cardiac disease, partial arrangement and use of analog

Info

Publication number
JPS6470418A
JPS6470418A JP63200280A JP20028088A JPS6470418A JP S6470418 A JPS6470418 A JP S6470418A JP 63200280 A JP63200280 A JP 63200280A JP 20028088 A JP20028088 A JP 20028088A JP S6470418 A JPS6470418 A JP S6470418A
Authority
JP
Japan
Prior art keywords
analog
formula
treatment
ser
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63200280A
Other languages
English (en)
Inventor
Buraipooru Geeruharuto
Kunore Yohen
Keenihi Buorufugangu
Rintsu Buorufugangu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS6470418A publication Critical patent/JPS6470418A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP63200280A 1987-08-14 1988-08-12 Auricular sodium diuretic factor for treatment of cardiac disease, partial arrangement and use of analog Pending JPS6470418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873727138 DE3727138A1 (de) 1987-08-14 1987-08-14 Verwendung von atrionatriuretischem faktor (anf), dessen teilsequenzen und analoga zur behandlung von herzerkrankungen

Publications (1)

Publication Number Publication Date
JPS6470418A true JPS6470418A (en) 1989-03-15

Family

ID=6333766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63200280A Pending JPS6470418A (en) 1987-08-14 1988-08-12 Auricular sodium diuretic factor for treatment of cardiac disease, partial arrangement and use of analog

Country Status (8)

Country Link
EP (1) EP0303243A3 (ja)
JP (1) JPS6470418A (ja)
KR (1) KR890003401A (ja)
AU (1) AU607527B2 (ja)
DE (1) DE3727138A1 (ja)
DK (1) DK454288A (ja)
PT (1) PT88259A (ja)
ZA (1) ZA885919B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1720562A4 (en) * 2004-01-15 2009-10-28 Scios Inc METHOD FOR TREATING CARDIAL REMODELING AFTER MYOCARDIAL DAMAGE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
US4652549A (en) * 1985-01-22 1987-03-24 Merck & Co., Inc. Cardiac anti-hypertrophic agents
EP0232078A3 (en) * 1986-01-31 1990-03-14 Merck & Co. Inc. Peptides having anf activity

Also Published As

Publication number Publication date
EP0303243A2 (de) 1989-02-15
DE3727138A1 (de) 1989-02-23
DK454288D0 (da) 1988-08-12
AU607527B2 (en) 1991-03-07
DK454288A (da) 1989-02-15
ZA885919B (en) 1989-04-26
KR890003401A (ko) 1989-04-14
AU2065288A (en) 1989-02-16
EP0303243A3 (de) 1991-04-03
PT88259A (pt) 1989-06-30

Similar Documents

Publication Publication Date Title
DE2540780C2 (ja)
DE3850690T2 (de) Basic fibroblast growth factor mutein, DNS und deren Verwendung.
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
DE1643273C3 (de) Antidiuretisch wirksames Polypeptid und Verfahren zu seiner Herstellung
IL69897A (en) Human pancreatic grf analogs,compositions comprising them and use thereof
AU589674B2 (en) GRF analogs
HK1040738A1 (en) Human parathyroid hormone modifications, preparation and use
HU196227B (en) Process for producing new cyclic vasopressin antagonist peptides and pharmaceutics comprising the same
DE3782010T2 (de) Vom calcitonin-gen abgeleitete peptidderivate.
MD1652F2 (en) Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein
DE69012377T2 (de) Polypeptid und dessen Herstellung.
DE3882279T2 (de) Zyklisches antikoagulierendes Peptid.
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
JPS6470418A (en) Auricular sodium diuretic factor for treatment of cardiac disease, partial arrangement and use of analog
Minematsu et al. Facile synthesis of Gramicidin S via cyclication of a linear pentapeptide
DE2341775C3 (de) In N-terminaler Stellung den Rest einer Aminooxysäure aufweisende Peptide mit ACTH-Wirkung, Verfahren zu ihrer Herstellung sowie diese Peptide enthaltende Arzneimittel
US5032576A (en) Method for controlling female moths using a peptide
HU207526B (en) Process for renaturating false recombinants of insuline precursors
Hruby et al. Synthesis and some pharmacological properties of tocinoic acid and deaminotocinoic acid
EP0687685A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES
DE69213628T2 (de) Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz
Brundish et al. Tritiated peptides. Part 2. Synthesis of two [3, 5-3 H 2-Tyr 2]-analogues of corticotrophin
SATO et al. Studies on β‐turn of peptides: IX. Effect of 1st and 4th amino acids of tetrapeptide sequences on their β‐turn preferences studied by CD spectra of their chromophoric derivatives
DE3936777A1 (de) Quervernetzte tumor-nekrose-faktoren
JPS6423899A (en) Novel physiologically active polypeptide